Medicure

Medicure is a specialty pharmaceutical company focused on the development and commercialization of therapeutics for the cardiovascular market. The company's flagship product is Aggrastat (tirofiban hydrochloride), an intravenous antiplatelet indicated for use in patients with acute coronary syndrome. Medicure also markets Zypitamag (pitavastatin) for the treatment of hypercholesterolemia and a generic Sodium Nitroprusside injection for the immediate reduction of blood pressure. The company operates primarily in the United States through its subsidiary, Medicure Pharma, and is headquartered in Winnipeg, Canada. Additionally, Medicure owns Marley Drug, a pharmacy that provides a direct-to-patient commercial platform for its products.